These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
952 related articles for article (PubMed ID: 25396757)
1. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis. Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757 [TBL] [Abstract][Full Text] [Related]
2. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling. Shin H; Kim JH; Lee YS; Lee YC Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241 [TBL] [Abstract][Full Text] [Related]
3. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway. Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106 [TBL] [Abstract][Full Text] [Related]
4. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer. Zhang Y; Miao Y; Yi J; Wang R; Chen L Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829 [TBL] [Abstract][Full Text] [Related]
5. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Ceppi P; Mudduluru G; Kumarswamy R; Rapa I; Scagliotti GV; Papotti M; Allgayer H Mol Cancer Res; 2010 Sep; 8(9):1207-16. PubMed ID: 20696752 [TBL] [Abstract][Full Text] [Related]
6. Wnt signaling pathway in non-small cell lung cancer. Stewart DJ J Natl Cancer Inst; 2014 Jan; 106(1):djt356. PubMed ID: 24309006 [TBL] [Abstract][Full Text] [Related]
7. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer. Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122 [TBL] [Abstract][Full Text] [Related]
8. Paired box 5 is a frequently methylated lung cancer tumour suppressor gene interfering β-catenin signalling and GADD45G expression. Zhao L; Li S; Gan L; Li C; Qiu Z; Feng Y; Li J; Li L; Li C; Peng W; Xu C; Wang Z; Hui T; Ren G; Tao Q; Xiang T J Cell Mol Med; 2016 May; 20(5):842-54. PubMed ID: 26843424 [TBL] [Abstract][Full Text] [Related]
10. Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma. Jayaraj P; Sen S; Sharma A; Chosdol K; Kashyap S; Rai A; Pushker N; Bajaj MS; Ghose S Br J Dermatol; 2012 Sep; 167(3):583-90. PubMed ID: 22458737 [TBL] [Abstract][Full Text] [Related]
11. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer. Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750 [TBL] [Abstract][Full Text] [Related]
12. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer. Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719 [TBL] [Abstract][Full Text] [Related]
13. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo. Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of SFRP5 promotes the metastasis and invasion of chondrosarcoma by expression inhibition and Wnt signaling pathway activation. Sheng W; Zhang ZC; Shi DY; Wang BC; Wu Q; Shao ZW; Yang SH; He TC; Liu JX Chem Biol Interact; 2018 Dec; 296():1-8. PubMed ID: 30125549 [TBL] [Abstract][Full Text] [Related]
15. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers. Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585 [TBL] [Abstract][Full Text] [Related]
16. Blockade of DNA methylation enhances the therapeutic effect of gefitinib in non-small cell lung cancer cells. Li XY; Wu JZ; Cao HX; Ma R; Wu JQ; Zhong YJ; Feng JF Oncol Rep; 2013 May; 29(5):1975-82. PubMed ID: 23440266 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type beta-catenin nuclear accumulation in lung tumorigenesis. Tseng RC; Lin RK; Wen CK; Tseng C; Hsu HS; Hsu WH; Wang YC Oncogene; 2008 Jul; 27(32):4488-96. PubMed ID: 18372914 [TBL] [Abstract][Full Text] [Related]
18. X-ray irradiation induced Disabled-2 gene promoter de-methylation enhances radiosensitivity of non-small-cell lung carcinoma cells. Ma S; Zhang WL; Leckey BD; Xu HT; Yang LH; Wang E J Exp Clin Cancer Res; 2018 Dec; 37(1):315. PubMed ID: 30547821 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of laminin-5-encoding genes in lung cancers. Sathyanarayana UG; Toyooka S; Padar A; Takahashi T; Brambilla E; Minna JD; Gazdar AF Clin Cancer Res; 2003 Jul; 9(7):2665-72. PubMed ID: 12855645 [TBL] [Abstract][Full Text] [Related]
20. [Effects of 5-Aza-2-deoxycytidine on DNA methylation of anti-oncogenes in non-small cell lung cancer cells]. Fang HL; Yu ZC; Zhu HB; Jin YT Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):658-63. PubMed ID: 23159077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]